C. Esche

发表

Chemokines: key players in innate and adaptive immunity.

L. Beck, C. Esche, C. Stellato, 2005, The Journal of investigative dermatology.

The use of dendritic cells for cancer vaccination.

M. Lotze, M. Shurin, C. Esche, 1999, Current opinion in molecular therapeutics.

Exon 15 BRAF Mutations Are Uncommon in Melanomas Arising in Nonsun-Exposed Sites

D. Sidransky, W. Westra, D. Goldenberg, 2004, Clinical Cancer Research.

FLT3-ligand administration inhibits liver metastases: role of NK cells.

M. Lotze, C. Maliszewski, V. Subbotin, 1998, Journal of immunology.

FLT 3-Ligand Administration Inhibits Liver Metastases : Role of NK Cells 1

M. Lotze, C. Maliszewski, V. Subbotin, 1998 .

FLT3: receptor and ligand. Biology and potential clinical application.

M. Lotze, M. Shurin, C. Esche, 1998, Cytokine & growth factor reviews.

Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice.

Simon C Watkins, M. Lotze, P. Robbins, 2002, Journal of experimental therapeutics & oncology.

Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo.

D. Carbone, M. Lotze, J. Ohm, 1999, Journal of immunology.

TNF-α protects dendritic cells from prostate cancer-induced apoptosis

M. Shurin, G. Pirtskhalaishvili, C. Esche, 2001, Prostate Cancer and Prostatic Diseases.

FLT 3 Ligand Administration Inhibits Tumor Growth in Murine Melanoma and Lymphoma 1

M. Lotze, C. Maliszewski, V. Subbotin, 2006 .

Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand

G. Chatta, G. Shurin, M. Shurin, 2004, Experimental Gerontology.

Differential regulation of epidermal and dermal dendritic cells by IL-12 and Flt3 ligand.

M. Lotze, C. Maliszewski, V. Subbotin, 1999, The Journal of investigative dermatology.

Tumor's other immune targets: dendritic cells

Simon C Watkins, M. Lotze, A. Lokshin, 1999, Journal of leukocyte biology.

Generation In Vivo and FLT 3 Ligand on Dendritic Cell Effect of Vascular Endothelial Growth Factor

D. Carbone, M. Lotze, J. Ohm, 1999 .

FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma.

M. Lotze, C. Maliszewski, V. Subbotin, 1998, Cancer research.

Effect in Mice Cancer-Induced Apoptosis and Antitumor Increases Their Resistance to Prostate L Transduction of Dendritic Cells with Bcl-x

G. Shurin, M. Shurin, G. Pirtskhalaishvili, 2022 .

Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity.

J. Kirkwood, M. Lotze, P. Robbins, 2000, The cancer journal from Scientific American.

Cytokine knockouts in contact hypersensitivity research.

A. Mamelak, D. Sauder, C. Esche, 2003, Cytokine & growth factor reviews.

CD154 inhibits tumor‐induced apoptosis in dendritic cells and tumor growth

Simon C Watkins, M. Lotze, P. Robbins, 1999, European journal of immunology.

Antitumor activities of IL-12 and mechanisms of action.

M. Lotze, M. Shurin, J. Péron, 1997, Chemical immunology.

Identification of delta- and mu-type opioid receptors on human and murine dendritic cells

B. Rabin, G. Shurin, M. Shurin, 2001, Journal of Neuroimmunology.

Human prostate cancer regulates generation and maturation of monocyte‐derived dendritic cells

H. Huland, G. Shurin, M. Shurin, 2001, The Prostate.

Chapter 53 – Dermatology

C. Esche, 2005 .

Novel Approach to the Evaluation of Primary Immunodeficiencies

B. Cohen, C. Esche, 2008 .

Tumor necrosis factor-alpha-promoted expression of Bcl-2 and inhibition of mitochondrial cytochrome c release mediate resistance of mature dendritic cells to melanoma-induced apoptosis.

J. Kirkwood, G. Shurin, M. Shurin, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Transduction of Dendritic Cells with Bcl-xL Increases Their Resistance to Prostate Cancer-Induced Apoptosis and Antitumor Effect in Mice1

A. Gambotto, Z. Yurkovetsky, G. Shurin, 2000, The Journal of Immunology.

Anti‐vascular endothelial growth factor receptor‐2 (Flk‐1/KDR) antibody suppresses contact hypersensitivity

D. Hicklin, R. Kerbel, A. Mamelak, 2004, Experimental dermatology.

M. Lotze, G. Shurin, M. Shurin, 2022 .

Lymph node biopsy results for desmoplastic malignant melanoma.

C. Balch, T. Barrett, C. Esche, 2007, Cutis.

Further evidence that syringolymphoid hyperplasia with alopecia is a cutaneous T-cell lymphoma.

P. Kind, C. Sander, H. Kutzner, 1998, Archives of Dermatology.

Keratinocytes in Atopic dermatitis: Inflammatory signals

Lisa A. Beck, L. Beck, C. Esche, 2004, Current allergy and asthma reports.

Is the mismatch repair deficient type of Muir-Torre syndrome confined to mutations in the hMSH2 gene?

P. Propping, R. Kruse, T. Ruzicka, 1996, Human Genetics.

Muir‐Torre syndrome: clinical features and molecular genetic analysis

P. Propping, R. Kruse, T. Ruzicka, 1997, The British journal of dermatology.

Human prostate cancer regulates generation and maturation of monocyte‐derived dendritic cells

H. Huland, G. Shurin, M. Shurin, 2001, The Prostate.

Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins

M. Lotze, G. Shurin, M. Shurin, 2000, British Journal of Cancer.

Murine Dendritic Cells Express Functional Delta‐Type Opioid Receptors

M. Lotze, M. Shurin, C. Esche, 1999, Annals of the New York Academy of Sciences.